🇮🇳 India Stock Screener ← Switch market ⚡ HerAI

Kovai Medical Center and Hospital Limited KOVAI NSEPHARMA

Healthcare · Medical Care Facilities · India
https://www.kmchhospitals.com
Company Profile ↓
₹5,782.00
+124.96% 1Y
Mkt Cap₹6,326.82 Cr
P/E25.04
P/B4.87
Div. Yield0.25%
52W High₹6,292.00
52W Low₹2,570.22
Book Value₹1,205.66
EPS (TTM)₹230.90

Company Overview

Kovai Medical Center and Hospital Limited operates a multispecialty hospital and its satellite centers in India. It operates through two segments, Healthcare Services and Education Services. The company offers outpatient and inpatient medical services in the fields of cardiology, cardiac anesthesiology, cardiovascular and thoracic surgery, comprehensive cancer center, critical care medicine, dentistry/faciomaxillary surgery, dermatology and cosmetic dermatology, electrophysiology, emergency services, endocrinology and diabetology, ENT/head and neck, fertility and reproductive medicine, gastroenterology and hepatology, general/laparoscopic surgery, hematology, internal medicine, interventional radiology, liver institute, laboratory medicine, neonatology, nephrology/urology, neurosciences, nuclear medicine and PET CT, obstetrics and gynecology, organ transplant program, orthopedics and joint replacement, pediatrics, pediatric surgery, pediatric intensive care unit, physical medicine and rehabilitation, psychological medicine, pulmonology, and rheumatology. It also provides preventive health check-ups. In addition, the company operates a medical college that provides postgraduate programs in neurology, pediatrics, psychiatry, orthopedics, and cardiopulmonary care. It serves out-patients, in-patients, and the common public. Kovai Medical Center and Hospital Limited was incorporated in 1985 and is based in Coimbatore, India.

Why Investors Should Care

Strong Return on Equity

Generates a return on equity of 18.5%, reflecting efficient use of shareholder capital.

Healthy Capital Returns

Return on capital employed stands at 20.6%.

Consistent Profit Growth

Net profit has compounded at 28.3% per year over the last five years.

Steady Revenue Expansion

Revenue has grown at a 18.2% CAGR over the past five years.

Reasonable Valuation

Trades at a P/E of 25.0, below the sector median of 36.4.

Healthy Margins

Maintains a net profit margin of 15.6%.

Recent Developments

  • Mar 2026 Revenue of ₹1,584.15 Cr (+15.7% YoY); net profit ₹244.46 Cr.
  • Trailing 12 Months Year-on-year growth — revenue +15.3%, earnings +20.7%.
  • 5-Year Trend Long-term compounding — revenue CAGR 18.2%, profit CAGR 28.3%.

Growth & Price Performance

Compounded Sales Growth

5 Years:18.24%
1 Year:15.30%

Compounded Profit Growth

5 Years:28.29%
1 Year:20.70%

Stock Price Performance

1 Year:+124.96%
6 Months:+2.81%
3 Months:-2.34%
1 Month:-7.13%

Highlights auto-generated from reported financials and price data; not investment advice. Verify with official filings before acting.

Technical Snapshot
52-Week Range 86% of range
₹2,570.22 ₹6,292.00
Trend Signals
  • Price vs 50-DMABelow
  • RSI (14)33.31 · Neutral
Price Performance
1M-7.13%
3M-2.34%
6M+2.81%
1Y+124.96%
Valuation vs Sector

P/E of 25.04 is below the sector median of 36.43 — relatively cheaper than peers.

Auto-generated from price history and fundamentals; not investment advice.

⚙Ad space

Price Chart

NSE TradingView

Fundamental Growth Charts

Interactive charts for Revenue, Net Income, EBITDA, Free Cash Flow, EPS, ROE, ROCE, Gross/Net/Operating Margin and more — switch metric and period using the dropdowns above. CAGR is computed across the displayed window (quarterly CAGR is annualised). Visual growth charts make it easy to spot multi-year compounding trends at a glance — far faster than reading raw numbers in a table.

PROS

  • Healthy ROCE of 20.6%.
  • Compounding revenue at 18.2% over 5 years.
  • Profit CAGR of 28.3% over 5 years.
  • Generates positive free cash flow.

CONS

No notable concerns flagged.

* The pros and cons are auto-generated from financial metrics.

⚙Ad space

Valuation

Stock P/E
25.04
Industry PE
36.43
Forward P/E est.
20.75
PEG Ratio
-
Book Value
₹1,205.66
Price to Book
4.87
P/S
3.91
EV/EBITDA
14.38
Dividend Yield
0.25%

Growth (CAGR)

Revenue 5Y
18.24%
Profit 5Y
28.29%
Revenue (YoY)
15.30%
Earnings (YoY)
20.70%

Profitability & Returns

ROCE
20.56%
ROE
18.53%
ROA
11.83%
Profit Margin
15.60%
Op Margin
21.38%
Gross Margin
48.25%
EPS (Latest Qtr)
₹54.55
EPS (TTM)
₹230.90

Balance Sheet & Liquidity

Debt/Equity
0.31
Quick Ratio
1.23
Current Ratio
1.29
Debt
₹402.75 Cr
Total Assets
₹2,066.08 Cr
Current Assets
₹420.94 Cr
Working Capital
₹94.20 Cr

Ownership

Promoter Holding
57.97%
Chg in Prom Hold
-0.63%
FII / Inst Holding
3.13%
Chg in FII Hold
0.02%

Financial Snapshot

Enterprise Value
₹6,326.82 Cr
Total Revenue (TTM)
₹1,643.02 Cr
EBITDA
₹452.40 Cr
Free Cash Flow
₹109.88 Cr
Operating Cash Flow
₹361.83 Cr
Shares Outstanding
₹1.09 Cr
Gross Margin
48.25%
Payout Ratio
0.00%

Peer comparison

Peer companies in the same sector (Healthcare).

#NameCMP ₹P/E Mkt CapDiv Yld % ROCE %ROE % Rev CAGR 5Y %Profit CAGR 5Y %
1 KOVAI Kovai Medical Center and Hospital Limited NSEPHARMA 5,782.00 25.04 ₹6,326.82 Cr 0.25% 20.56% 18.53% 18.24% 28.29%
2 SUNPHARMA Sun Pharmaceutical Industries Limited NIFTY50NSEAIPHARMA 1,745.10 34.62 ₹4.19 L Cr 0.91% 17.94% 13.74% 10.39% 10.65%
3 DIVISLAB Divi's Laboratories Limited NSEPHARMA 9,190.00 83.58 ₹2.44 L Cr 0.32% 18.96% 15.32% 10.98% 12.08%
4 TORNTPHARM Torrent Pharmaceuticals Limited NSEPHARMA 4,553.80 72.74 ₹1.73 L Cr 0.81% 9.05% 25.79% 13.27% 20.22%
5 ZYDUSLIFE Zydus Lifesciences Limited NSEPHARMA 1,117.30 24.90 ₹1.11 L Cr 0.09% 19.04% 18.59% 16.55% 36.99%
6 LENSKART Lenskart Solutions Limited NIFTY_MIDNSEPHARMA 631.35 164.41 ₹1.09 L Cr 0.00% 7.21% 5.65% 35.38% 66.99%
7 APOLLOHOSP Apollo Hospitals Enterprise Limited NIFTY50NSEAIPHARMA 7,600.00 52.32 ₹1.09 L Cr 0.25% 19.20% 20.48% 14.85% 33.34%
8 LAURUSLABS Laurus Labs Limited NIFTY_MIDNSEPHARMA 2,012.50 99.48 ₹1.09 L Cr 0.12% 19.53% 16.77% 3.77% 4.00%
9 CIPLA Cipla Limited NIFTY50NSEAIPHARMA 1,314.00 31.51 ₹1.06 L Cr 0.99% 14.86% 11.27% 7.23% 11.45%
Financial Statements Quarterly Results · Profit & Loss · Balance Sheet · Cash Flows · Ratios

Quarterly Results

Figures in INR.

Metric Mar 2025Jun 2025Sep 2025Dec 2025Mar 2026
Revenue 356.64 Cr373.59 Cr390.74 Cr406.62 Cr413.20 Cr
Cost of Revenue 150.83 Cr151.07 Cr161.50 Cr159.32 Cr173.76 Cr
Gross Profit 205.81 Cr222.52 Cr229.24 Cr247.30 Cr239.44 Cr
Operating Expenses 129.27 Cr142.64 Cr149.02 Cr158.95 Cr157.53 Cr
Operating Income 76.54 Cr79.88 Cr80.22 Cr88.35 Cr81.91 Cr
EBITDA 107.48 Cr111.49 Cr113.41 Cr123.16 Cr119.05 Cr
Interest Expense 8.65 Cr9.17 Cr8.74 Cr8.42 Cr5.68 Cr
Pretax Income 74.32 Cr76.38 Cr77.89 Cr87.14 Cr84.28 Cr
Tax Provision 19.62 Cr19.16 Cr19.03 Cr22.12 Cr24.59 Cr
Net Income 54.70 Cr57.23 Cr58.86 Cr65.02 Cr59.69 Cr
Diluted EPS 49.9952.3053.7959.4254.55

Profit & Loss (Annual)

Figures in INR.

Metric Mar 2008Mar 2009Mar 2010Mar 2011Mar 2012Mar 2013Mar 2014Mar 2015Mar 2016Mar 2017Mar 2018Mar 2022Mar 2023Mar 2024Mar 2025Mar 2026
Revenue 88.00 Cr110.00 Cr130.00 Cr175.00 Cr222.00 Cr297.00 Cr334.00 Cr402.00 Cr465.00 Cr531.00 Cr592.00 Cr-958.19 Cr1,133.84 Cr1,369.74 Cr1,584.15 Cr
Cost of Revenue ------------458.44 Cr528.43 Cr823.77 Cr960.93 Cr
Gross Profit ------------499.74 Cr605.41 Cr545.97 Cr623.22 Cr
Operating Expenses 73.00 Cr91.00 Cr104.00 Cr138.00 Cr178.00 Cr226.00 Cr261.00 Cr307.00 Cr373.00 Cr406.00 Cr463.00 Cr-316.23 Cr353.05 Cr254.66 Cr289.52 Cr
Operating Income 10.00 Cr15.00 Cr21.00 Cr30.00 Cr31.00 Cr55.00 Cr57.00 Cr73.00 Cr71.00 Cr101.00 Cr95.00 Cr-183.51 Cr252.36 Cr291.31 Cr333.70 Cr
EBITDA 15.00 Cr19.00 Cr26.00 Cr37.00 Cr44.00 Cr71.00 Cr73.00 Cr95.00 Cr92.00 Cr125.00 Cr129.00 Cr-284.32 Cr362.48 Cr407.81 Cr467.05 Cr
Interest Expense 3.00 Cr4.00 Cr5.00 Cr11.00 Cr17.00 Cr27.00 Cr24.00 Cr20.00 Cr17.00 Cr15.00 Cr13.00 Cr-39.97 Cr32.78 Cr32.67 Cr31.97 Cr
Pretax Income 7.00 Cr11.00 Cr17.00 Cr20.00 Cr16.00 Cr31.00 Cr37.00 Cr59.00 Cr62.00 Cr92.00 Cr89.00 Cr-155.22 Cr237.56 Cr277.55 Cr325.69 Cr
Tax Provision 2.87 Cr3.85 Cr5.61 Cr7.60 Cr4.16 Cr10.23 Cr13.32 Cr20.65 Cr21.70 Cr32.20 Cr31.15 Cr-39.45 Cr57.83 Cr68.61 Cr81.23 Cr
Net Income 4.00 Cr7.00 Cr12.00 Cr12.00 Cr12.00 Cr20.00 Cr24.00 Cr39.00 Cr41.00 Cr60.00 Cr58.00 Cr-115.77 Cr179.73 Cr208.95 Cr244.46 Cr
Diluted EPS 3.856.5310.6011.0610.9118.6721.7235.2137.1254.8952.99--164.25190.95223.41

Balance Sheet (Annual)

Figures in INR.

Metric Mar 2008Mar 2009Mar 2010Mar 2011Mar 2012Mar 2013Mar 2014Mar 2015Mar 2016Mar 2017Mar 2018Mar 2022Mar 2023Mar 2024Mar 2025Mar 2026
Total Assets 93.00 Cr126.00 Cr173.00 Cr283.00 Cr338.00 Cr344.00 Cr350.00 Cr384.00 Cr428.00 Cr462.00 Cr606.00 Cr-1,438.12 Cr1,438.23 Cr1,799.91 Cr2,066.08 Cr
Current Assets ------------295.05 Cr250.41 Cr330.44 Cr420.94 Cr
Cash & Equivalents ------------17.95 Cr59.60 Cr14.30 Cr63.72 Cr
Inventory ------------13.72 Cr14.70 Cr15.62 Cr20.25 Cr
Receivables ------------16.72 Cr12.52 Cr23.77 Cr30.25 Cr
Total Liabilities ------------719.08 Cr549.70 Cr713.75 Cr746.82 Cr
Current Liabilities ------------181.16 Cr203.13 Cr269.86 Cr326.74 Cr
Long Term Debt ------------447.37 Cr253.18 Cr348.33 Cr317.35 Cr
Total Debt 38.00 Cr70.00 Cr108.00 Cr192.00 Cr228.00 Cr209.00 Cr184.00 Cr163.00 Cr158.00 Cr125.00 Cr202.00 Cr-510.91 Cr310.36 Cr415.34 Cr402.75 Cr
Total Equity 24.00 Cr30.00 Cr40.00 Cr51.00 Cr61.00 Cr79.00 Cr101.00 Cr137.00 Cr174.00 Cr234.00 Cr289.00 Cr-719.04 Cr888.54 Cr1,086.16 Cr1,319.27 Cr
Shares Outstanding ------------1.09 Cr1.09 Cr1.09 Cr1.09 Cr

Cash Flows (Annual)

Figures in INR.

Metric Mar 2008Mar 2009Mar 2010Mar 2011Mar 2012Mar 2013Mar 2014Mar 2015Mar 2016Mar 2017Mar 2018Mar 2022Mar 2023Mar 2024Mar 2025Mar 2026
Operating Cash Flow -15.00 Cr24.00 Cr42.00 Cr56.00 Cr61.00 Cr68.00 Cr97.00 Cr86.00 Cr99.00 Cr87.00 Cr-262.91 Cr344.13 Cr334.61 Cr361.83 Cr
Investing Cash Flow --23.00 Cr-64.00 Cr-97.00 Cr-77.00 Cr-9.00 Cr-12.00 Cr-80.00 Cr-115.00 Cr-83.00 Cr-191.00 Cr--126.86 Cr-138.17 Cr-333.83 Cr-230.18 Cr
Financing Cash Flow -27.00 Cr31.00 Cr71.00 Cr17.00 Cr-48.00 Cr-52.00 Cr-43.00 Cr-24.00 Cr-50.00 Cr60.00 Cr--85.70 Cr-243.49 Cr62.09 Cr-58.37 Cr
Capital Expenditure --23.00 Cr-65.00 Cr-98.00 Cr-77.00 Cr-10.00 Cr-15.00 Cr-37.00 Cr-71.00 Cr-36.00 Cr-128.00 Cr--127.40 Cr-138.42 Cr-353.10 Cr-251.95 Cr
Free Cash Flow --8.00 Cr-41.00 Cr-56.00 Cr-21.00 Cr51.00 Cr53.00 Cr60.00 Cr15.00 Cr63.00 Cr-41.00 Cr-135.52 Cr205.71 Cr-18.49 Cr109.88 Cr
Net Change in Cash -18.00 Cr-9.00 Cr16.00 Cr-3.00 Cr5.00 Cr4.00 Cr-26.00 Cr-53.00 Cr-34.00 Cr-45.00 Cr-50.35 Cr-37.53 Cr62.87 Cr73.28 Cr

Ratios (Annual)

Figures in %.

Metric Mar 2008Mar 2009Mar 2010Mar 2011Mar 2012Mar 2013Mar 2014Mar 2015Mar 2016Mar 2017Mar 2018Mar 2022Mar 2023Mar 2024Mar 2025Mar 2026
Gross Margin % ------------52.2%53.4%39.9%39.3%
Operating Margin % 11.4%13.6%16.2%17.1%14.0%18.5%17.1%18.2%15.3%19.0%16.0%-19.2%22.3%21.3%21.1%
Net Margin % 4.5%6.4%9.2%6.9%5.4%6.7%7.2%9.7%8.8%11.3%9.8%-12.1%15.9%15.3%15.4%
ROE % 16.7%23.3%30.0%23.5%19.7%25.3%23.8%28.5%23.6%25.6%20.1%-16.1%20.2%19.2%18.5%
ROCE % ------------14.6%20.4%19.0%19.2%

Shareholding Pattern

Insiders
57.97%
Institutions
3.13%
Public Float
7.44%

Analyst View

Loading analyst coverage…

Latest News

Recent headlines for KOVAI

Google News Sun, 18 Oct 2026

Kovai Medical Center AGM passes all resolutions with 99.9% support - scanx.trade

<a href="https://news.google.com/rss/articles/CBMitgFBVV95cUxPaUN6d0dDM1ctMGl3Y3ZTR2hFcEVRZUJtS0thY2s1R2JlWXM5bEVFZHo1bEhJeG95bE1JeTNiWTNtSEt4aVZDUmt4dEpCR0RRTUx1Wmt3VDAzMHZuQkFfdFlsZW5tNmZNdFE5Z25kVkdnWHllR1N0ZkdKNDRxVkZVUzlNTFRjSFVCZjNMYj…

Google News Sun, 18 Oct 2026

KMCH revises Q4FY26 net profit to ₹633.53 crore after tax correction - scanx.trade

<a href="https://news.google.com/rss/articles/CBMiowFBVV95cUxNN0t4eTVsQVFESVZaWmtTRUN6NmhFd1UteUFJS2lkbDU5ZV80ZzFSWWdsLU1XalBiekk0N1NFMUx6RnVIMUtVN0NMRzJWX1RobkZBZGQxZ3ZkanFVSmszU1o4bHJMMzJBdW1VYkRla3RQYUNfTmt5U1A1Zk41SkNYUk5TY1B5eDhhci1McW…

Google News ue, 01 Sep 2026

Kovai Medical Center & Hospital Ltd. Shareholding Pattern – Promoters, FIIs & DIIs - Value Research

<a href="https://news.google.com/rss/articles/CBMinAFBVV95cUxOUHZyaGx6aGplNmZmVGVVajdmaEx5NjFqNFZYU1ltM0U2Q2wwMFJQTm8wVVhyQTFLQXlwdldHbWMyZmNzVElsV0lSVXJDek9mSk16YVRUYmhNMjVfbWhFWVRvTmNwY2xTeFF6WDUya09fQV9tVHdtUW9yeHUyUE4wb05uU0hJY0dYOXRSeE…

Google News Fri, 07 Aug 2026

Kovai Medical Q1 FY27 Results: Revenue Rs 431 Cr, PAT Rs 69 Cr and Key Highlights - Univest

<a href="https://news.google.com/rss/articles/CBMidkFVX3lxTE9lY2Jvb0Z1eFoyejZUcnhKV2dKaVViTUJuSl9uTFFLc0t5d1JXOWJ4d2gtODFiUVpHNjFRNDhMTzFYU3hWSjdGWnkxVHBrZlRBa3NXMGNaNllqNTA2dUU5S3JjNUx4Mm5tSUR6Ni1qekV0RXJReWc?oc=5" target="_blank">Kovai Me…

Google News Fri, 22 May 2026

Kovai Medical Q4 profit rises 9% to ₹59.7 crore as revenue jumps 14% - Sahi

<a href="https://news.google.com/rss/articles/CBMipwFBVV95cUxNT2FKOWctOG9SYmFfRkFtUUxyLWxoTVh3ZXBfUGp4M3FaVmUtNFdxbzdrZ2Z2Q1hyeTdXZGZOcUpMQ3dyNkgyTHQyWldPTWk5NUxLWHp4cW9aLUhhYms2MXFGOGtMMXVhZW9jbDdyemJoc3NPVmxwbWpIbmlMLXV5WTV5dGN5cHE2cnktOF…

Google News ue, 15 Sep 2026

Kovai Medical Center & Hospital Slips Below ₹6,000 Mark as KOVAI.NS Faces Profit-Booking Pressure - Equal Weight ETF - siam.in

<a href="https://news.google.com/rss/articles/CBMi0AFBVV95cUxPa211eHRzLUhZNnJhOGtlZHlfQ0gxNWZJSmhBVG9sNk5ocVFYZWhUSk5iWmNWaTNVM21TT0N6OVZYTld2cmhLdWpjckhEaUlRTG1KbnFaMXBuVHpWTVhOLTVhdjBCRlZicmlfS01vSWpLOGRweTZEbmt0cVpJZFh4MnFBWmxiYVljX2pWV3…

KOVAI — Frequently Asked Questions

What is the current share price of Kovai Medical Center and Hospital Limited (KOVAI)?

As of 2026-10-23 04:58 IST, Kovai Medical Center and Hospital Limited (KOVAI) trades at ₹5,782.00 on NSE. Its 52-week range is ₹2,570.22 to ₹6,292.00.

What is the market capitalisation of KOVAI?

Kovai Medical Center and Hospital Limited (KOVAI) has a market capitalisation of ₹6,326.82 Cr on NSE.

What is the P/E ratio of KOVAI?

KOVAI trades at a trailing price-to-earnings (P/E) ratio of 25.04. The industry average P/E is 36.43. Its price-to-book (P/B) ratio is 4.87.

Does KOVAI pay a dividend?

Kovai Medical Center and Hospital Limited (KOVAI) currently offers a dividend yield of 0.25%.

What is the return on equity (ROE) of KOVAI?

KOVAI has a return on equity (ROE) of 18.53%. Its return on capital employed (ROCE) is 20.56%.

Is KOVAI a good stock to buy?

This page provides a data-driven analysis of Kovai Medical Center and Hospital Limited (KOVAI), including valuation ratios, profitability, growth trends, auto-generated pros and cons, peer comparison and AI exposure. Review these fundamentals alongside your own research and risk tolerance. This is informational content, not investment advice.

Explore More

📊 Healthcare Sector 🔍 All Stock Screens 📈 Technical Screens 💰 Fundamental Screens 🔄 Swing Trading Setups 📐 Chart Patterns 📅 Earnings Calendar 📋 All India Stocks
⚙Ad space